Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
REPAIR: SBRT Potentiated by Metformin for Prostate Bed Relapse
NCT04536805Phase 2Active, not recruiting
- Sponsor
- Institut Cancérologique de l'Ouest
- Start
- Nov 2020
- Primary completion
- Nov 2031
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of liquid metformin (Aspargo Labs) in prostate cancer (PCa), sponsored by Institut Cancérologique de l'Ouest. Started Nov 2020; status: active, not recruiting.
02
Drugs
liquid metformin (Aspargo Labs)
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT04536805.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04536805.